MONEYWEB
LIVESTREAM
Share rises as much as 2.9% on Tuesday.
By Naomi Kresge, BloombergÂ
21 Apr 2021 06:05
Image: Bloomberg
Johnson & Johnson will restart deliveries of its Covid-19 vaccine to the European Union after the blocâs drug regulator said the benefits of the shot outweigh the risks of a possible link with cases of rare blood clots.
The European Medicines Agency assessment on Tuesday echoed its review of the vaccine from AstraZeneca, which has also been linked with the rare clot. In both cases, the regulator noted that Covid can be fatal and the use of vaccines is crucial to fighting the virus.
EU Regulator: Possible Link Between Johnson & Johnson Vaccine And Rare Blood Clots
wfuv.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wfuv.org Daily Mail and Mail on Sunday newspapers.
EU Regulator: Possible Link Between Johnson & Johnson Vaccine And Rare Blood Clots
wnpr.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wnpr.org Daily Mail and Mail on Sunday newspapers.
EU regulator finds possible link between Johnson & Johnson Covid vaccine and blood clots
The European Medicines Agency said the benefits of the jab far outweigh the very small risk of blood clots
20 April 2021 • 5:00pm
The EMA said a warning about unusual blood clots should be added to the vaccine s labels as a very rare side effect
Credit: Reuters
The EU’s drug regulator has said there is a possible link between Johnson & Johnson s Covid-19 vaccine and rare blood clots.
The European Medicines Agency (EMA) said a warning about unusual blood clots with low blood platelets should be added to the vaccine s labels as a very rare side effect of the single shot jab.